drugset / Trial / NCT04983160
Crossover Clinical Trial, Randomized, Double Blind, Placebo Controlled Trial
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to determine the effect of inhibiting xanthine oxidase with allopurinol in patients with chronic kidney disease in asymptomatic hyperuricemia endothelial injury and vascular repair mechanisms.
Timeline
- Start
- 2014-02-26
- Primary completion
- 2016-04-29
- Completion
- 2016-04-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Allopurinol | Small molecule | — | — |